Head, Government Affairs, Sanofi US
Ed Greissing is responsible for the company’s Chronic Disease Prevention and Wellness Program, Health Innovation, Academic and Scientific Affairs, Federal and State government relations, public policy, reimbursement, global institutional relations, regional and local alliance development, patient advocacy, civic action, and corporate social responsibility. Ed joined Sanofi with many years of experience in business-focused global government affairs and consulting.
David Meeker, M.D.
President and Chief Executive Officer, Sanofi Genzyme
As the President and Chief Executive Office of Sanofi Genzyme, David Meeker is responsible for leading the Rare Diseases and Multiple Sclerosis businesses globally. In his 18 years with Genzyme, David has served as Chief Operating Officer, President of the Rare Disease business unit and as a Medical Director on cystic fibrosis gene therapy program. David has led the integration of the Genzyme and Sanofi businesses and delivered strong double-digit sales growth.
Vice President, Chronic Disease Prevention & Wellness, Sanofi US
Angela Moskow currently serves as the VP for Chronic Disease Prevention and Wellness at Sanofi US. Angela has experience in the area of diabetes, having previously worked within the Sanofi Insulin Franchise.
John Spinnato, Esq.
Vice President, North America Corporate Social Responsibility, Sanofi US
President, Sanofi Foundation for North America
John Spinnato is Vice President, North America Corporate Social Responsibility for Sanofi US. In this capacity, he also serves as President of the Sanofi Foundation for North America. John has accumulated experience in both the pharmaceutical and aviation industries, and has previously worked with Sanofi in Paris.